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The myenteric plexus and the submucosal plexus make up the enteric nervous system (ENS), and control
intestinal motility, local perfusion and physiologic function. Local inﬂammation of the myenteric plexus,
by lymphocytic or eosinophilic cells is associated with intestinal pseudo-obstruction. We describe the
youngest reported case of eosinophilic myenteric ganglionitis (EMG), and the only reported case of EMG
occurring with Hirschsprung’s disease (HD). Recently, a term male neonate under our care failed to pass
meconium and was diagnosed with both EMG and HD. He was treated with fecal diversion and dietary
modiﬁcation. He did not require anti-inﬂammatory medical therapy. He subsequently underwent
resection of the colonic segment affected by HD, and his EMG resolved with dietary modiﬁcation by the
time of ostomy takedown. He continues to tolerate a regular pediatric diet, meets normal growth
milestones, and requires no maintenance anti-inﬂammatory therapy for EMG.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.The presentation of eosinophilic myenteric ganglionitis can be
similar to that of Hirschsprung’s disease. However, there has been
no clinical or pathologic link of eosinophilic inﬁltration to the
presence of aganglionosis and the subsequent diagnosis of
Hirschsprung’s disease. Here we present the ﬁrst patient in the
literature to have an initial diagnosis of eosinophilic myenteric
ganglionitis and an ultimate diagnosis Hirschsprung’s disease. Our
patient also represents the youngest and only reported patient to
have a diagnosis of eosinophilicmyenteric ganglionitis as a neonate.1. Case report
Our patient is a term infant male, born to a 39 year-old G2P2
mother with Hepatitis C via uncomplicated Caesarian section. The
patient failed to pass meconium and developed bilious emesis onery, Department of Surgery,
7223, Chapel Hill, NC 27599-
97.
cLean).
Inc. Open access under CC BY-NC-ND licenDOL 1. Suction rectal biopsy showed an absence of ganglion cells
and neural hypertrophy consistent with HD. The patient was then
taken to the operating room on DOL 7 for diagnostic laparoscopy
with planned endorectal pull-through procedure. During the diag-
nostic laparoscopy,multiple frozen section biopsies of the colon and
rectum demonstrated that ganglion cells were present. A transanal
open rectal biopsy showed aganglionosis on frozen section analysis;
thus, the decision was made to create a sigmoid colostomy and
mucous ﬁstula. The patient did well post-operatively and was dis-
charged home tolerating full feeds with normal colostomy output.
The ﬁnal pathology report showed an absence of ganglion cells in
the anorectal mucosa with few ganglion cells within the suspected
transition zone. Additionally, increased numbers of eosinophils
were identiﬁed within the myenteric plexus and surrounding
smooth muscle of the suspected transition zone, aganglionic sig-
moid colon and rectum consistent with eosinophilic myenteric
ganglionitis. There weremore than 10 cells/hpf, and the eosinophils
were noted to be degrannulating around the myenteric plexus.
These results were conﬁrmed by outside review.
The patient was referred to pediatric gastroenterology for
outpatient management of his enteric neuropathy. Following fecal
diversion, the patient’s serum showed eosinophilia to
0.9  109 cells/L (0e0.4  109 cells/L). The patient experienced
feeding intolerance, anorexia, and occasional emesis that improvedse.
Fig. 1. H&E staining of rectal biopsy taken at the time of the patient’s initial diagnostic
laparoscopy, at 20magniﬁcation. This specimen shows eosinophilic inﬁltration of the
myenteric plexus.
Fig. 2. H&E staining of the biopsied specimen taken at the time of the patient’s initial
diagnostic laparoscopy, at 400 magniﬁcation. Specimen shows primarily eosinophilic
inﬂammatory reaction around the patient’s myenteric plexus. Arrows mark location of
eosinophils, isolated within the myenteric plexus with evidence of degranulation.
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Following dietary modiﬁcation, the eosinophilia resolved and the
patient began to gain weight and meet appropriate developmental
milestones. Following multi-disciplinary case review, no anti-in-
ﬂammatory therapy was administered.
At 3 months of age the patient underwent open transanal rectal
biopsy prior to colostomy takedown to conﬁrm the diagnosis of HD.
Pathology showed an absence of ganglion cells, prominent neural
hypertrophy, and no eosinophilic inﬁltrate. The patient underwent
endorectal pull-through procedure for HD with resection of the
affected colonic segment at 6 months of age. Final surgical pa-
thology was consistent with HD and the absence of EMG. The pa-
tient’s post-operative course was complicated by perianal
excoriation secondary to frequent and loose stools, which was
improved with loperamide and local wound care. Overall the pa-
tient has done well post-operatively by tolerating a regular pedi-
atric diet and continuing to meet developmental milestones.
2. Discussion
Hirschsprung’s disease (HD) is the most common cause of
congenital intestinal dysmotility occurring in 1 in 4400 to 1 in 7000
live births [1,2]. The hallmark symptom of HD is a failure to pass
meconium within the ﬁrst 24 hours of life. Patients with HD can
also present with abdominal distention, vomiting, intestinal
obstruction, severe constipation, and enterocolitis. HD is charac-
terized by aganglionosis in the colon, rectum, and rarely the small
intestine that results in abnormal intestinal motility or obstruction.
Hirschsprung’s disease is characterized by aganglionosis, neural
hypertrophy, and increased acetylcholinesterase staining within
the affected specimen. The ganglion cell is an important contributor
to the capability of the enteric nervous system to control intestinal
motility. Developmentally, ganglion cells arise from neural crest
cells. The lack of ganglion cells in HD occurs due to failed survival,
migration, proliferation, and differentiation of neural crest cells
[3,4]. A hostile microenvironment can also lead to conditions that
prevent neural crest cells from thriving and differentiating into
enteric ganglion cells [3,5e8].
Myenteric ganglionitis is an inﬂammatory neuronal enteropathy
that leads to intestinal pseudo-obstruction. The symptoms in
myenteric ganglionitis may mimic those seen in HD. There are two
histopathologic forms of myenteric ganglionitis [9]. The most
common form is lymphocytic ganglionitis where there is inﬁltra-
tion of the myenteric plexus by CD4 and CD8 positive lymphocytes.
In lymphocytic ganglionitis, neuronal degeneration may lead to
complete loss of neurons. Eosinophilic myenteric ganglionitis is the
less common form of myenteric ganglionitis that leads to intestinal
dysfunction. In eosinophilic myenteric ganglionitis, eosinophils
inﬁltrate into the myenteric plexus. Instead of causing neuronal
degeneration and loss, the eosinophils cause functional impairment
of myenteric neurons through inﬁltration itself and release of hu-
moral factors [10]. To date there are ﬁve reported cases of intestinal
dysmotility related to eosinophilic myenteric ganglionitis in pa-
tients ranging from one month to 93 years of age [10e12] (Fig. 1).
We have described the ﬁrst patient to present in the neonatal
period with the diagnosis of both EMG and HD. HD is a common
birth defect, but EMG is rare with no large case series to evaluate
the incidence of EMG or its natural history. Our patient is only the
sixth reported case of EMG, and the ﬁrst to be diagnosed prior to
one month of age [10e12]. However, confounding this diagnosis is
the rarely reported presence of eosinophils isolated to the transi-
tion zone in a case series of 7 reported patients with HD [13]. These
transitional zone eosinophils extend from the myenteric plexus to
the mucosa in 5 of the 7 patients. The localization of eosinophils
within the transition zone has led others to suggest that they aresecondary to the obstructive pathology associated with the transi-
tion from ganglionic to aganglionic segments of the affected
myenteric plexus [13e15]. However, as opposed to these previous
reports of eosinophilic inﬁltrates in HD, our patient had eosinophils
extending into the aganglionic segments of bowel, isolated to the
myenteric plexus, with visual evidence of eosinophilic degranula-
tion (Fig. 2). Additionally, our patient had clinical evidence of
enteric myopathy that required dietary modiﬁcation for the reso-
lution of symptoms and peripheral eosinophilia even after colonic
diversion for HD. Taken together, it appears that the eosinophilic
inﬁltrate in our patient was distinct from the previously described
non-speciﬁc eosinophilic inﬁltrates described in HD patients by
others [13e15]. However, given the uncertain function, frequency,
and quantiﬁcation of eosinophils in HD, and the rarity of EMG, it is
difﬁcult to deﬁnitively distinguish the two entities.
HD and EMG are both neuropathic intestinal motility disorders
related to abnormalities in the myenteric ganglion cells. HD is a
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development in the colon and rectum. EMG differs in that it is an
acquired ganglionitis and not associated with numeric, functional,
or morphologic evidence of myenteric denervation. Instead eosin-
ophils are attracted to ganglion cells, and they cause functional
impairment through inﬁltration or the release of humoral factors
[10,12]. Eosinophils may be attracted to ganglion cells through the
release of Interleukin 5 (IL-5) [12]. HD is permanent, and EMG may
be temporary. Our patient had biopsies of the rectum that
demonstrated aganglionosis consistent with HD. Similar to the re-
ported cases of EMG, the colonic biopsies from our patient showed
ﬁndings of eosinophilic inﬁltration of the myenteric plexus and
eosinophil degranulation within the myenteric plexus [12] (Fig. 2).
In all reported cases of EMG biopsies demonstrated the presence of
eosinophils within themyenteric plexus. Three of the reported EMG
patients were evaluated and ruled out for the diagnosis of HD
[11,12].
HD and EMG may have a similar presentation. HD patients may
present with a large intestinal obstruction, poor feeding, vomiting,
enterocolitis, or severe constipation. In EMG, patients develop a
pseudo-obstruction. Except for enterocolitis, EMG patients can
present with similar symptoms to patients with HD, which can
make it difﬁcult to distinguish the patients by clinical criteria.
Furthermore, due to similar radiographic ﬁndings HD and EMG
cannot be differentiated based upon imaging. One distinguishing
clinical characteristic that may be present in EMG is the presence of
an eosinophilia. Eosinophilia was present in our patient and two of
the previously reported cases of EMG [11,12].
Treatment of HD and EMG is different based upon the differ-
ences in their pathogenesis. In HD, surgery must be performed to
resect the aganglionic segment of intestine and restore intestinal
continuity. EMG patients are managed with dietary modiﬁcation,
immunosuppression, anti-inﬂammatory medications, and surgery
or a combination of these modalities. Dietary modiﬁcation may
range from the reduction of exposure to allergenic foods (wheat,
egg, cow’s milk) to the use of an amino acid based formula. Three of
the described patients were started and maintained on an amino
acid based formula, but this did not lead to the resolution of EMG
[11,12]. In four of the previously described cases, the use of steroids
was the only form of deﬁnitive treatment for EMG. Some patients
were subsequently maintained on azathioprine or sulfasalazine
[12]. The use of these two anti-inﬂammatory drugs did not induce a
cure of the EMG. Surgery was curative for EMG in the reported case
of the 93 year-old patient, but in all other cases a laparotomy was
performed for a possible mechanical bowel obstruction. In all cases,
the laparotomies were negative and did not lead to a resolution of
EMG [10].
In our case, our patient experienced obstructive symptoms and
was taken to the operating room where no mechanical cause of
obstruction was identiﬁed and a colostomy was created after a
biopsy showed aganglionosis. Final review of the colonic biopsies
showed eosinophilia within the myenteric plexus. One rectal bi-
opsy demonstrated an absence of ganglion cells and neural hy-
pertrophy without the presence of eosinophilia. After the
diagnosis of EMG was determined, dietary modiﬁcation with an
amino acid based formula was started. Contrary to other cases the
eosinophilia resolved with dietary modiﬁcation alone, and our
patient did not require steroids for resolution of symptoms. Afterthe eosinophilia was shown to be resolved on an open rectal bi-
opsy, a deﬁnitive resection and pull-through procedure was per-
formed to treat the HD.
Previous studies have identiﬁed factors associated with EMG,
including: paraneoplastic syndrome, infection, or primary neuro-
logic disorders [12]. None of these conditions were present in our
patient. It appears that this case of EMG was idiopathic. However,
an association with maternal hepatitis C cannot be ruled out as the
underlying cause and may be considered if it appears to be asso-
ciated with future cases of EMG. Additionally, there is no current
evidence linking the presence of neonatal EMG with the develop-
ment of HD in our patient, and no other reported cases of EMG have
had ﬁndings consistent with HD to suggest a link.3. Conclusion
This case represents the ﬁrst case of EMG and HD presenting
concomitantly, and the case represents the youngest reported case
of EMG in the literature. As opposed to previously reported cases,
our patient’s EMG improved with dietary modiﬁcation and did not
require maintenance immunosuppressive therapy. Following EMG
resolution, our patient beneﬁtted from a staged surgical approach
with sigmoid colostomy and mucous ﬁstula and resection of the
colonic segment affected by HD. It is hoped that this case report will
increase awareness of the rare, but possible presentation of EMG
with HD.References
[1] Orr JD, Scobie WG. Presentation and incidence of Hirschsprung’s disease. Br
Med J (Clin Res Ed) 1983;287:1671.
[2] Spouge D, Baird PA. Hirschsprung disease in a large birth cohort. Teratology
1985;32:171e7.
[3] Butler Tjaden NE, Trainor PA. The developmental etiology and pathogenesis of
Hirschsprung disease. Transl Res 2013;162:1e15.
[4] Webster W. Embryogenesis of the enteric ganglia in normal mice and in mice
that develop congenital aganglionic megacolon. J Embryol Exp Morphol 1973;
30:573e85.
[5] Clavel C, Gaillard D, Lallemand A, Birembaut P. Distribution of ﬁbronectin and
laminin during development of the human myenteric plexus and Hirsch-
sprung’s disease. Gastroenterol Clin Biol 1988;12:193e7.
[6] Hoehner JC, Wester T, Påhlman S, Olsen L. Alterations in neurotrophin and
neurotrophin-receptor localization in Hirschsprung’s disease. J Pediatr Surg
1996;31:1524e9.
[7] Langer JC, Betti PA, Blennerhassett MG. Smooth muscle from aganglionic
bowel in Hirschsprung’s disease impairs neuronal development in vitro. Cell
Tissue Res 1994;276:181e6.
[8] Tosney KW, Watanabe M, Landmesser L, Rutishauser U. The distribution of
NCAM in the chick hindlimb during axon outgrowth and synaptogenesis. Dev
Biol 1986;114:437e52.
[9] Justinich C, Katz A, Gurbindo C, Lepage G, Chad Z, Bouthillier L, et al. Elemental
diet improves steroid-dependent eosinophilic gastroenteritis and reverses
growth failure. J Pediatr Gastroenterol Nutr 1996;23:81e5.
[10] Chander B, Fiedler P, Jain D. Eosinophilic myenteric ganglionitis: a case of
intestinal pseudo-obstruction in a 93-year-old female. J Clin Gastroenterol
2011;45:314e6.
[11] Ooms AH, Verheij J, Hulst JM, Vlot J, van der Starre C, de Ridder L, et al.
Eosinophilic myenteric ganglionitis as a cause of chronic intestinal pseudo-
obstruction. Virchows Arch 2012;460:123e7.
[12] Schäppi MG, Smith VV, Milla PJ, Lindley KJ. Eosinophilic myenteric ganglionitis
is associated with functional intestinal obstruction. Gut 2003;52:752e5.
[13] Lowichik A, Weinberg AG. Eosinophilic inﬁltration of the enteric neural
plexuses in Hirschsprung’s disease. Pediatr Pathol Lab Med 1997;17:885e91.
[14] Kapur RP. Practical pathology and genetics of Hirschsprung’s disease. Semin
Pediatr Surg 2009;18:212e23.
[15] Reyes-Mugica M. Hirschsprung disease: review. Pathol Case Rev 2000;5:51e9.
